leuvectin
Gene therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 1999 (NCT00004050)
Timeline
Indications
Studied for
Mechanism of action
- Interleukin-2Supplementation
IL2 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- leuvectin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00005072 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2000 | National Cancer Institute (NCI), University of California, Los Angeles, Vical |
| NCT00004050 | Phase 2 | Jun 1, 1999 | National Cancer Institute (NCI), University of California, Los Angeles, Vical |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 1999 |
| University of California, Los Angeles | Academic/Hospital | 2 | 0 | 1 | 1999 |
| Vical | For profit | 2 | 2 | 1 | 1999 |
3 organizations
Page 1 / 1